vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $17.7M, roughly 1.8× Ballard Power Systems Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs 15.6%, a 978.9% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

BLDP vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.8× larger
OPRX
$32.2M
$17.7M
BLDP
Higher net margin
BLDP
BLDP
978.9% more per $
BLDP
994.4%
15.6%
OPRX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLDP
BLDP
OPRX
OPRX
Revenue
$17.7M
$32.2M
Net Profit
$176.5M
$5.0M
Gross Margin
74.8%
Operating Margin
26.6%
Net Margin
994.4%
15.6%
Revenue YoY
-0.2%
Net Profit YoY
6535.9%
EPS (diluted)
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
OPRX
OPRX
Q4 25
$32.2M
Q3 25
$17.7M
$26.1M
Q2 25
$29.2M
Q1 25
$21.9M
Q4 24
$32.3M
Q3 24
$-12.3M
$21.3M
Q2 24
$18.8M
Q1 24
$19.7M
Net Profit
BLDP
BLDP
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$176.5M
$779.0K
Q2 25
$1.5M
Q1 25
$-2.2M
Q4 24
$-78.0K
Q3 24
$-9.1M
Q2 24
$-4.0M
Q1 24
$-6.9M
Gross Margin
BLDP
BLDP
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
156.5%
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
BLDP
BLDP
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
BLDP
BLDP
OPRX
OPRX
Q4 25
15.6%
Q3 25
994.4%
3.0%
Q2 25
5.2%
Q1 25
-10.0%
Q4 24
-0.2%
Q3 24
-42.8%
Q2 24
-21.3%
Q1 24
-35.0%
EPS (diluted)
BLDP
BLDP
OPRX
OPRX
Q4 25
$0.27
Q3 25
$0.04
Q2 25
$0.08
Q1 25
$-0.12
Q4 24
$0.00
Q3 24
$-0.50
Q2 24
$-0.22
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$128.3M
Total Assets
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$16.6M
Q1 25
$16.6M
Q4 24
$13.4M
Q3 24
$16.1M
Q2 24
Q1 24
Total Debt
BLDP
BLDP
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
BLDP
BLDP
OPRX
OPRX
Q4 25
$128.3M
Q3 25
$122.3M
Q2 25
$119.3M
Q1 25
$116.3M
Q4 24
$117.0M
Q3 24
$114.5M
Q2 24
$121.0M
Q1 24
$122.5M
Total Assets
BLDP
BLDP
OPRX
OPRX
Q4 25
$176.9M
Q3 25
$170.3M
Q2 25
$169.3M
Q1 25
$167.8M
Q4 24
$171.2M
Q3 24
$165.2M
Q2 24
$172.9M
Q1 24
$176.4M
Debt / Equity
BLDP
BLDP
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
OPRX
OPRX
Operating Cash FlowLast quarter
$5.7M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.03×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$5.7M
$3.2M
Q2 25
$4.6M
Q1 25
$3.9M
Q4 24
$198.0K
Q3 24
$-6.6M
$1.8M
Q2 24
$782.0K
Q1 24
$2.1M
Free Cash Flow
BLDP
BLDP
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
BLDP
BLDP
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
BLDP
BLDP
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
BLDP
BLDP
OPRX
OPRX
Q4 25
1.41×
Q3 25
0.03×
4.11×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons